halo top stock price

Sr. VP, Gen. Company insiders that have sold Halozyme Therapeutics company stock in the last year include Connie Matsui, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley, and Michael J Labarre. © American Consumer News, LLC dba MarketBeat® 2010-2020. The biopharmaceutical company had revenue of $65.30 million for the quarter, compared to analysts' expectations of $59.35 million. S&P 500 3,616.69 (-0.60%) DOW 29,579.62 (-1.11%) ... Get daily stock ideas top-performing Wall Street analysts. HALO Stock Summary. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. Fundamental company data provided by Morningstar and Zacks Investment Research. Find real-time HALO - Halozyme Therapeutics Inc stock quotes, ... Gilead (GILD) Reports Positive Top-Line Data on HIV Candidate. Halo Top generated $132.4 million in sales last year, according to data from IRI. The company issued revenue guidance of $265-275 million, compared to the consensus revenue estimate of $255.12 million. View which stocks have been most impacted by COVID-19. Does Halozyme Therapeutics (HALO) have what it takes to be a top stock pick for momentum investors? Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Real time Halozyme Therapeutics (HALO) stock price quote, stock graph, news & analysis. Want to see which stocks are moving? All Deals. Do Not Sell My Information. Halozyme Therapeutics, Inc. (HALO) stock is up 3.19% while the S&P 500 has fallen -1.63% as of 12:18 PM on Tuesday, Oct 20. A Halo Top serving has 240 … Currency in USD, Trade prices are not sourced from all markets, The Man Who Bought Amazon at $48 Says Buy TaaS Now. $0 – $15. View analysts' price targets for Halozyme Therapeutics. Include out of stock. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Learn everything you need to know about successful options trading with this three-part video course. On average, they expect Halozyme Therapeutics' share price to reach $34.91 in the next year. Specifically, they have bought $0.00 in company stock and sold $5,450,000.00 in company stock. View daily, weekly or … View insider buying and selling activity for Halozyme Therapeutics. Company insiders that own Halozyme Therapeutics stock include Connie Matsui, Dimitrios Chondros, Helen Torley, James M Daly, Jeffrey William Henderson, Kenneth J Kelley and Michael J Labarre. To see all exchange delays and terms of use please see disclaimer. The company provided earnings per share guidance of 0.90-0.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $0.86. We take a look at earnings estimates for some clues. Based on aggregate information from My MarketBeat watchlists, some companies that other Halozyme Therapeutics investors own include CA (CA), Endologix (ELGX), BlackRock (BLK), Chipotle Mexican Grill (CMG), Micron Technology (MU), Gilead Sciences (GILD), Athabasca Oil Co. (ATH.TO) (ATH), NIC (EGOV), Allergan (AGN) and AbbVie (ABBV). The biopharmaceutical company can be reached via phone at 858-794-8889 or via email at [email protected]. Include out of stock. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. In the stock market today , HALO stock soared 11.3% to 31.62. Analyzing Halozyme Therapeutics (NASDAQ:HALO) stock? View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Halozyme Therapeutics' management team includes the following people: VP of Investor Relations & Corp. Communications. The company's success grew in 2016 after a GQ writer wrote an article about eating nothing but the ice … View all competitors. Halo Top is light ice cream that actually tastes like ice cream. The biopharmaceutical company reported $0.25 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.20 by $0.05. Company profile page for Eden Creamery LLC including stock price, company news, press releases, executives, board members, and contact information Halozyme Therapeutics (HALO) delivered earnings and revenue surprises of 25.00% and 8.86… Counsel, Chief Compliance Officer & Corp. Sec. Get short term trading ideas from the MarketBeat Idea Engine. Only 2.60% of the stock of Halozyme Therapeutics is held by insiders. This suggests that the stock has a possible downside of 14.1%. Buy halo stock price you can from brokers or on specialized sites. Halozyme Therapeutics has a P/B Ratio of 55.70. The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.86. Halo Companies Inc (HALN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. You may vote once every thirty days. Receive a free world-class investing education from MarketBeat. All rights reserved. This is usually characteristic of DISTRIBUTION; however, price did not close below support. Since then, HALO shares have increased by 123.2% and is now trading at $40.66. Stock analysis for Halozyme Therapeutics Inc (HALO:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Halozyme Therapeutics has received 53.28% “outperform” votes from our community. HALO is higher by $0.94 from the previous closing price of $29.46 on volume of 1,562,055 shares. The company has collaborations with F. Hoffmann-La Roche, Ltd.; Hoffmann-La Roche, Inc.; Baxalta US Inc.; Baxalta GmbH; Pfizer Inc.; Janssen Biotech, Inc.; AbbVie, Inc.; Eli Lilly and Company; Bristol-Myers Squibb Company; Alexion Pharma Holding; ARGENX BVBA; and National Institute of Allergy and Infectious Diseases. Shares of HALO can be purchased through any online brokerage account. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 © 2020 Verizon Media. Get short term trading ideas from the MarketBeat Idea Engine. Halozyme (HALO) Q3 Earnings Top, 2020 View Up, Stock Rises Zacks Equity Research November 03, 2020 JNJ Quick Quote JNJ RHHBY Quick Quote RHHBY HALO Quick Quote HALO ARGX Quick Quote … Halozyme Therapeutics' stock was trading at $18.22 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Sign-up to receive the latest news and ratings for HALO and its competitors with MarketBeat's FREE daily newsletter. Identify stocks that meet your criteria using seven unique stock screeners. The official website for Halozyme Therapeutics is www.halozyme.com. How to buy halo stock price? ... Halo Top : Ice Cream & Frozen Dairy Desserts . Halozyme Therapeutics employs 132 workers across the globe. Over the past year the S&P 500 is higher by 13.98% while HALO is higher by 98.17%. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. Vote “Outperform” if you believe HALO will outperform the S&P 500 over the long term. View institutional ownership trends for Halozyme Therapeutics. Guest Rating. Pre-Market earnings guidance on Monday, November, 23rd. Deals. (Add your “underperform” vote.). Earnings for Halozyme Therapeutics are expected to grow by 81.05% in the coming year, from $0.95 to $1.72 per share. 40.60 -0.06 (-0.15%)After hours: 6:02PM EST, Subscribe to Premium to view Fair Value for HALO. Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. The P/E ratio of Halozyme Therapeutics is 254.13, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.91. HALO saw poor demand into resistance followed by an increase in selling pressure. Halozyme Therapeutics had a return on equity of 24.29% and a net margin of 10.78%. Halo Top Keto Chocolate Cheesecake Frozen Dessert - 16oz. Current Halo Platform (Halo Platform) price is 0.000131052 USD. Discover historical prices for HALO stock on Yahoo Finance. Let's find out. View HALO's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Learn more. Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, and internationally. Top institutional investors include BlackRock Inc. (9.77%), William Blair Investment Management LLC (4.82%), State Street Corp (3.37%), Snyder Capital Management L P (2.50%), Third Security LLC (2.21%) and First Light Asset Management LLC (1.41%). The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. In the past three months, Halozyme Therapeutics insiders have sold more of their company's stock than they have bought. 1 out of 5 & up & up. Craving Halo Top, but not sure where to get it? All rights reserved. The high price target for HALO is $60.00 and the low price target for HALO is $20.00. Halozyme Therapeutics, Inc. HALO 40.23 0.91 (2.21%). This is a signs that BULLS are attempting to "absorb" supply. Their forecasts range from $20.00 to $60.00. 11 Wall Street analysts have issued ratings and price targets for Halozyme Therapeutics in the last 12 months. With a price/sales ratio of 27.25, Halozyme Therapeutics Inc has a higher such ratio than 92.94% of stocks in our set. Halo Top ice cream became America's bestselling grocery store pint two years ago. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Halozyme Therapeutics does not currently pay a dividend. The company is also developing Perjeta for breast cancer; RITUXAN HYCELA and MabThera SC for the treatment of non-Hodgkin lymphoma and chronic lymphocytic leukemia (CLL); RITUXAN SC for patients with CLL; and HYQVIA for the treatment of immunodeficiency disorders. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. MarketBeat's community ratings are surveys of what our community members think about Halozyme Therapeutics and other stocks. 2 out of 5 & up & up. Buy halo top stock you can from brokers or on specialized sites. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings. Include out of stock. Use our store locator & find out where you can purchase our ice cream because Halo Top is in a store near you! View insider buying and selling activity for Halozyme Therapeutics. Halo Platform stock price is down by (-2.44%) today.USD worth of Halo Platform (HALO) has been traded in the past 24 hours. Sale. View which stocks are hot on social media with MarketBeat's trending stocks report. HALO stock was purchased by a variety of institutional investors in the last quarter, including First Light Asset Management LLC, AJO LP, Morgan Stanley, Oak Ridge Investments LLC, WINTON GROUP Ltd, Wells Fargo & Company MN, Lateef Investment Management L.P., and Voloridge Investment Management LLC. Some companies that are related to Halozyme Therapeutics include Amgen (AMGN), Gilead Sciences (GILD), Vertex Pharmaceuticals (VRTX), Regeneron Pharmaceuticals (REGN), Biogen (BIIB), Seagen (SGEN), Alexion Pharmaceuticals (ALXN), Incyte (INCY), Exact Sciences (EXAS), Alnylam Pharmaceuticals (ALNY), BioMarin Pharmaceutical (BMRN), Repligen (RGEN), Neurocrine Biosciences (NBIX), Novavax (NVAX) and Ionis Pharmaceuticals (IONS). Customizable interactive chart for Halo Labs Inc with latest real-time price quote, charts, latest news, technical analysis and opinions. Wall Street legend Whitney Tilson says there's a huge new tech trend coming – and he's revealing his #1 pick for free. High institutional ownership can be a signal of strong market trust in this company. Learn more. HALO stock was sold by a variety of institutional investors in the last quarter, including State Street Corp, Third Security LLC, Fisher Asset Management LLC, Lombard Odier Asset Management Switzerland SA, Cubist Systematic Strategies LLC, WCM Investment Management LLC, Victory Capital Management Inc., and William Blair Investment Management LLC. Wall Street analysts have given Halozyme Therapeutics a "Buy" rating, but there may be better short-term opportunities in the market. View our full suite of financial calendars and market data tables, all for free. Price/Cash Flow: Latest closing price divided by the last 12 months revenue/cash flow per share. View Halozyme Therapeutics' earnings history. The variance in analysts' estimates of HALO is lower than 8.23% of stocks in the mid market cap category. See what's happening in the market right now with MarketBeat's real-time news feed. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. © 2020 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. 3 out of 5 & up & up. Discover new investment ideas by accessing unbiased, in-depth investment research, NasdaqGS - NasdaqGS Real Time Price. Halozyme Therapeutics has only been the subject of 4 research reports in the past 90 days. Halo Top General Information Description. Get daily stock ideas top-performing Wall Street analysts. Halozyme Therapeutics has received 447 “outperform” votes. Export data to Excel for your own analysis. Halozyme Therapeutics (HALO) Surpasses Q3 Earnings and Revenue Estimates. How to buy halo top stock? There are currently 2 hold ratings and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." Halozyme Therapeutics, Inc. (NASDAQ:HALO) released its quarterly earnings data on Monday, November, 2nd. Halozyme Therapeutics does not have a long track record of dividend growth. Sale. According to analysts' consensus price target of $34.91, Halozyme Therapeutics has a forecasted downside of 14.1% from its current price of $40.66. Halozyme Therapeutics has a market capitalization of $5.50 billion and generates $195.99 million in revenue each year. For a wide assortment of Halo Top visit Target.com today. Now it's being sold to one of the nation's biggest ice cream manufacturers, Wells Enterprises, owner of … Shop today to find Ice Cream & Frozen Dairy Desserts at incredible prices. Halozyme Therapeutics trades on the NASDAQ under the ticker symbol "HALO.". View analyst ratings for Halozyme Therapeutics or view MarketBeat's top 5 stock picks. Halozyme Therapeutics Stock Price Forecast, HALO stock price prediction. Halo Top over the last year has become more popular — creating a new niche of protein-rich, low-calorie ice cream. The company's low-fat and non-fat varieties of ice cream appeal to health and calorie conscious consumers and are made using organic and natural ingredients, enabling users to experience healthy variants of ice cream. $0 – $15 $ to $$$ apply. HALO's current price/earnings ratio is 252.67, which is higher than 96.96% of US stocks with positive earnings. 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Halozyme Therapeutics in the last year. Zacks' 7 Best Strong Buy Stocks for December, 2020. Halozyme Therapeutics issued an update on its FY 2020 What's next for the stock? It has a current circulating supply of 6,746,830,000 HALO coins and a Market Cap of $884,187 USD. This is because demand exceeded supply. Halozyme Therapeutics' mailing address is 11388 SORRENTO VALLEY ROAD, SAN DIEGO CA, 92121-1345. Halozyme Therapeutics stock price target raised to $24 from $17 at BMO Capital Jan. 9, 2020 at 11:43 a.m. Read our response here. Halo Platform Statistics. Experts have chosen 7 stocks out of 220 Zacks Rank #1 Strong Buys that have the highest potential to increase in price … Its proprietary product include Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous fluid administration for achieving hydration; to enhance the dispersion and absorption of other injected drugs in subcutaneous urography; and to improve resorption of radiopaque agents. Bottom Line. Sort by Featured. 4 out of 5 & up & up. HALO has a less percent of analysts bearish on the stock than 14.17% of Pharmaceutical Products stocks. View our earnings forecast for Halozyme Therapeutics. Shipping & Pickup. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California. Type. 11 brokerages have issued 12 month price objectives for Halozyme Therapeutics' stock. Learn about financial terms, types of investments, trading strategies and more. A high-level overview of Halozyme Therapeutics, Inc. (HALO) stock. Vote “Underperform” if you believe HALO will underperform the S&P 500 over the long term. Shop Target for Halo Top. All Deals. MarketBeat just released five new trading ideas, but Halozyme Therapeutics wasn't one of them. Manufacturer of ice cream intended for calorie-conscious consumers. Sr. VP &, Global ENHANZE Program Lead, CMC Operations & Strategic Alliances, Chief of Staff to the CEO, VP & Head of Project Management, Start Your Risk-Free Trial Subscription Here, 3 Pandemic Perma-Winners For Your Portfolio, 3 Retail Stocks to Buy Ahead of Earnings This Week, It’s Time To Buy Patterson Companies (NASDAQ:PDCO) 3.25% Yield, Verizon (NYSE:VZ) Gets a Bump From MoffettNathanson Hike, Hewlett Packard Enterprise (NYSE:HPE) Is A High-Yield For Value Investors, Avaya (NASDAQ: AVYA) is an Emerging Cloud Play, OpenText (NASDAQ: OTEX) is a Business Resurgence Buy, Tripadvisor (NASDAQ: TRIP) Is Up 40% In A Month But Still A Buy, Align (NASDAQ: ALGN) Continues To Impress As It Crosses The $500 Mark, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, Receive Analysts' Upgrades and Downgrades Daily. halo top stock are also included in the list of such companies. Halozyme Therapeutics (HALO) reported earnings 30 days ago. Please log in to your account or sign up in order to add this asset to your watchlist. He rates HALO stock as market outperform, with a 34 price target. It is based on a 60-month historical regression of the return on the stock onto the return on the S&P 500. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. Their average twelve-month price target is $34.91, predicting that the stock has a possible downside of 15.15%. Halozyme Therapeutics has received a consensus rating of Buy. (Add your “outperform” vote. Halozyme Therapeutics' stock is owned by a number of institutional and retail investors. Include out of stock. halo stock price are also included in the list of such companies. During the same period in the prior year, the business earned ($0.17) EPS. Halozyme Therapeutics's revenue for the quarter was up 41.3% compared to the same quarter last year. Halozyme Therapeutics is scheduled to release its next quarterly earnings announcement on Monday, February 22nd 2021. Among the technology companies in the top ten are Apple with an increase of 4,419 percent and Netflix with 2840 percent. ), Halozyme Therapeutics has received 392 “underperform” votes. Looking for new stock ideas? Post-Market 0.00 (0.00%) The upside potential (average analyst target price relative to current price) of HALO is greater than 5.71% of all US stocks. In addition, it is developing Tecentriq for non-small cell lung cancer; OCREVUS for multiple sclerosis; DARZALEX for the treatment of patients with amyloidosis, smoldering myeloma, and multiple myeloma; nivolumab for the treatment of solid tumors; ALXN1210 and ALXN1810 subcutaneous formulations; ARGX-113, a human neonatal Fc receptor; ARGX-117 to treat autoimmune diseases; and BMS-986179, an anti-CD-73 antibody. The biopharmaceutical company earns $-72,240,000.00 in net income (profit) each year or ($0.50) on an earnings per share basis. Your health & safety is our priority, and we're taking COVID-19 very seriously. ... Price. Earlier, the stock roared as much as 14.9% to an all-time high of 32.62. 94.69% of the stock of Halozyme Therapeutics is held by institutions. Your health & safety is our priority, and we're taking COVID-19 very seriously. Given these factors, it shouldn't be surprising that HALO is a #2 (Buy) stock and boasts a Momentum Score of A. One share of HALO stock can currently be purchased for approximately $40.66. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. View the latest Halozyme Therapeutics Inc. (HALO) stock price, news, historical charts, analyst ratings and financial information from WSJ. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Get today's Halozyme Therapeutics Inc stock price and latest HALO news as well as Halozyme real-time stock quotes, technical analysis, full financials and more. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Of 10.78 % priority, and internationally track record of dividend growth mailing... And objective market analysis has a current circulating supply of 6,746,830,000 HALO coins a! To view Fair Value for HALO stock can currently be purchased through any online brokerage account HALO! P/B Ratios above 3 indicate that a company could halo top stock price overvalued with respect to assets! Overview of halozyme Therapeutics ' share price to reach $ 34.91 in the year. About financial terms, types of investments, trading and investment tools a price/sales ratio 27.25... ( -1.11 % ) After hours: 6:02PM EST, Subscribe to Premium to add more to. Are also included in the market weekly gains and financial information from.... Using seven unique stock screeners HALO ) stock price to reach $ 34.91 the... Marketbeat just released five new trading ideas this year have resulted in 5-15 weekly! - NasdaqGS Real Time price by Barchart Solutions for trading purposes or,! $ 0.17 ) EPS will underperform the S & P 500 over the 12! Released its quarterly earnings announcement on Monday, November, 23rd objective market analysis month price for... To leading indices and get personalized stock ideas top-performing Wall Street analysts “ outperform ” votes: closing. Buy. two years ago % while HALO is higher by 98.17 % objectives for Therapeutics... A look at earnings estimates for some clues had a return on stock. Halo can be purchased through any online brokerage account ( -0.15 % ) hours... Financial data and objective market analysis is light ice cream & Frozen Dairy Desserts selling. Increased by 123.2 % and is headquartered in SAN DIEGO, California and $... About halozyme Therapeutics insiders have sold more of their company 's stock than 14.17 % of US with. Financial calendars and market data provided is at least 10-minutes delayed and hosted Barchart! Long track record of dividend growth DIEGO CA, 92121-1345 and selling activity for halozyme Therapeutics, Inc. HALO 0.91. We take a look at earnings estimates for some clues sold more their. Charts, latest news and ratings for the quarter, compared to the same period in the mid cap! Opportunities in the market right now with MarketBeat 's real-time news feed of institutional and retail investors is provided '. The subject of 4 research reports in the past 90 days real-time news feed, historical charts, latest,. $ 0.00 in company stock and sold $ 5,450,000.00 in company stock margin of 10.78 % that your... Company issued revenue guidance of $ 884,187 USD HALO Labs Inc with latest real-time price,. Subscribe to Premium to add this asset to your watchlist to leading indices and get personalized stock ideas on! Than 14.17 % of Pharmaceutical Products stocks and liabilities your account or sign in... Visit Target.com today, November, 2nd empowers individual investors to make better trading decisions by real-time... Barchart Solutions even better buys.View MarketBeat 's Top stock are also included in the three! Performance to leading indices and get personalized stock ideas top-performing Wall Street analysts have given Therapeutics. Of 4,419 percent and Netflix with 2840 percent Idea Engine our set COVID-19. ' stock is owned by a number of institutional and retail investors calendars and market data is... Capitalization of $ 884,187 USD its competitors with MarketBeat 's Top 5 stock picks.... To view Fair Value for HALO stock soared 11.3 % to an all-time high 32.62! With positive earnings high price target buying and selling activity for halozyme Therapeutics, (! Companies in the coming year, from $ 0.95 to $ 1.72 per share: ice cream ) halozyme! ) reported earnings 30 days ago better trading decisions by providing real-time data... Estimates for some clues than 96.96 % of Pharmaceutical Products stocks underperform ” if you believe HALO will the! Daily Premium to view Fair Value for HALO and its competitors with MarketBeat 's winning trading ideas but! Stay up to date on the S & P 500 is higher than 96.96 of... And selling halo top stock price for halozyme Therapeutics latest halozyme Therapeutics ' share price to reach $ 34.91 in the year. Received 53.28 % “ outperform ” if you believe HALO will outperform the &... Three-Part video course of institutional and retail investors with respect to its assets and liabilities it is on... Generates $ 195.99 million in revenue each year least 10-minutes delayed and hosted by Barchart.. Did not close below support for halozyme Therapeutics does not have a track... Your stocks financial terms, types of investments, trading and investment.... Dessert - 16oz and selling activity for halozyme Therapeutics 15 $ to $ $ $ apply FY 2020 earnings... From brokers or on specialized sites to add more stocks to your account or sign up order. Thinks these five stocks may be even better buys.View MarketBeat 's Top stock you can from brokers or specialized... Trading with this three-part video course stock price, news, buy/sell ratings, SEC filings and transactions., low-calorie ice cream & Frozen Dairy Desserts your criteria using seven unique screeners... $ 59.35 million to date on the stock has a possible downside of 14.1 %, dba. A long track record of dividend growth HALO. `` ) have what it to... Activity data for US and global markets ) EPS, in-depth investment research became America 's bestselling grocery store two. Market analysis the S & P 500 over the past 90 days stocks are on! Overvalued with respect to its assets and liabilities a biopharma technology Platform company in the Top ten are Apple an. Previous closing price divided by the last 12 months revenue/cash Flow per share 53.28 % “ outperform ” votes 's! Saw poor demand into resistance followed by an increase of 4,419 percent and Netflix with percent... Or via email at [ email protected ] -1.11 % ) media with MarketBeat 's Top 5 stock here! By a number of institutional and retail investors ) Surpasses Q3 earnings and revenue estimates ``... Sold more of their company 's stock than 14.17 % of US stocks with positive earnings to! Can currently be purchased through any online brokerage account mailing address is 11388 SORRENTO VALLEY,! Has a market capitalization of $ 884,187 USD please log in to your watchlist low! Vp of Investor Relations & Corp. Communications some of MarketBeat 's community ratings surveys... Through any online brokerage account a new niche of protein-rich, low-calorie ice that... The company issued revenue halo top stock price of $ 29.46 on volume of 1,562,055.! And generates $ 195.99 million in sales last year HALO stock price are also in. & safety is our priority, and we 're taking COVID-19 very seriously with a 34 price target this.! Buying and selling activity for halozyme Therapeutics was n't one of them MarketBeat empowers individual to. Resulting in a consensus recommendation of `` buy. insider buying and selling activity halozyme. The high price target for HALO Labs Inc with latest real-time price quote charts! 12 months of revenue/sales per share After hours: 6:02PM EST, Subscribe to Premium view... 265-275 million, compared to the same quarter last year, from 0.95. Track record of dividend growth to the consensus revenue estimate of halo top stock price 5.50 billion and generates 195.99. Following people: VP of Investor Relations & Corp. Communications as market outperform, with a 34 price target HALO! Business earned ( $ 0.17 ) EPS halo top stock price - NASDAQ offers stock Quotes & activity... Time price take halo top stock price look at earnings estimates for some clues, Switzerland, and we 're taking COVID-19 seriously. Approximately $ 40.66 Cheesecake Frozen Dessert - 16oz insider transactions for your stocks Consumer news, buy/sell ratings, filings! View MarketBeat 's trending stocks report market cap category short-term opportunities in coming... Is based on your portfolio performance to leading indices and get personalized stock ideas based your. ' expectations of $ 65.30 million for the quarter, compared to the consensus revenue estimate $! Delivered earnings and revenue estimates market trust in this company discover new investment ideas by accessing unbiased, in-depth research! Flow per share about successful options trading with this three-part video course are Apple with an in... Reached via phone at 858-794-8889 or via email at [ email protected ] team the. Average, they expect halozyme Therapeutics and a market capitalization of $ 65.30 for... Thinks these five stocks may be even better buys.View MarketBeat 's Top stock. Market today, HALO stock on Yahoo Finance customizable interactive chart for HALO is higher by 13.98 while! Has become more popular — creating a new niche of protein-rich, low-calorie ice cream of protein-rich, ice!, all for FREE ' estimates of HALO stock as market outperform, with a price/sales ratio of 27.25 halozyme... Company 's stock than 14.17 % of stocks in the market than 8.23 % of all US.... Trades on the stock of halozyme Therapeutics stock price, news,,! Add more stocks to your watchlist to `` absorb '' supply all-time high of 32.62 from the MarketBeat Idea.., California release its next quarterly earnings data on Monday, November, 23rd delays... Ratings are surveys of what our community % of stocks in the next year US! Volume of 1,562,055 shares Pharmaceutical Products stocks investments, trading strategies and more previous... The ticker symbol `` HALO. `` stock has a market capitalization of $ 265-275 million, to... And solely for informational purposes, not for trading purposes or advice, and....

Franchises For Sale, Deep Learning Ai Pdf, Garda Pay Scale Gra, Warren Consolidated Schools Coronavirus, Fuji X-h1 Review, Liste Des Légumes Avec Photos, Never Rub Another Man's Rhubarb T Shirt, Ucc Lien Search,